INTRODUCTION
Bacillm antbracis produces two protein exotoxins. Protective antigen (PA), combined with either lethal factor (LF) or oedema factor (EF), constitutes lethal toxin or oedema toxin, respectively (Beall e t al., 1962; Stanley & Smith, 1961) . After PA (83 kDa) binds to a cellular receptor (Escuyer & Collier, 1991) , cleavage occurs at a trypsin-sensitive site localized to amino acid residues 164-Arg-Lys-Lys-Arg-167 (Leppla e t al., 1987; Singh e t al., 1989) . Proteolysis releases a 20 kDa, N-terminal fragment (PA20), exposing a binding site for either LF or EF on the 
0002-0247
receptor-bound, 63 kDa, C-terminal fragment, PA63 (Leppla e t a/., 1987 (Leppla e t a/., , 1990 Novak et al., 1992) . The toxin complex enters the cell by receptor-mediated endocytosis, and LF and EF are thought to be transported into the cytosol (Friedlander, 1986 ; Gordon e t al., 1988) . Recently, Milne e t a/. (1994) showed that PA63 forms heptameric oligomers, postulated as functioning in the translocation event. Lethal toxin causes severe pulmonary oedema and death in susceptible animals (Beall et al., 1962; Fish e t al., 1968; Stanley & Smith, 1961) , and is rapidly cytolytic for macrophages in vitro (Friedlander, 1986) . LF has recently been reported to exhibit homology to zinc metalloendopeptidases (Klimpel e t al., 1994; Kochi e t al., 1994) . Oedema toxin causes oedematous lesions (Fish et al., 1968; Stanley & Smith, 1961) attributed to the calmodulin-dependent adenylate cyclase activity of EF (Leppla, 1982) . Based upon the model, PA thus contains domains involved in binding to cell receptors, binding of either catalytic moiety LF or EF, and translocating the toxin effector molecule into the cytoplasm .
This work compares the ability of mAbs produced against PA to neutralize lethal toxin activity with their ability to inhibit binding of PA to cells and of LF to cell-bound PA.
PA fragments of 47 kDa (PA47) and 37 kDa (PA37) ( Fig. 1 ; were prepared by limited digestion of PA (3-5 mg ml-l) with chymotrypsin, type VII (Nor-p-tosyl-Llysine chloromethyl ketone (TLCK)-treated, 125 pg), in 2 3 mM NaH,PO,, 7.5 mM Na,HPO,, 0.15 M NaC1, pH 7.3 (PBS), for 10 min at room temperature. The reaction was stopped by adding PMSF and the sample was adjusted to 5 M urea and 50 mM HEPES. Chromatography was then performed on Monos resin (Pharmacia-LKB) using 50 mM HEPES, 5 M urea buffer, pH 7.55. Fractions were eluted with a linear gradient of 0-0.5 M NaCl in 50 mM HEPES, 5 M urea buffer, pH 7-55. Fragments were identified by SDS-PAGE. Urea present in the PA47 and PA37 fragments was lowered to < 0.5 M by buffer exchange to 20 mM HEPES, 50 mM NaC1, pH 7-55, by using 30 kDa cutoff membranes. Fragments were stored at -70 OC.
To generate PA17 (Fig. l) , PA ( 3 5 mg ml-l) was subjected to limited digestion with chymotrypsin, type VII (125 pg) for 5 min followed by trypsin, type XI11 (12.5 pg) for 5 min on ice. The sample was adjusted to 5 M urea and 50 mM MES after adding PMSF. The digest was then chromatographed over Monos resin using 50 mM MES, 5 M urea buffer, pH 6.15. Fractions were eluted with a linear gradient of 0-1 M NaCl in 50 mM MES, 5 M urea, pH 6.15. PA17 was identified by SDS-PAGE. To ensure the removal of PA47 reactive fragments, the PA17 preparation was diluted fourfold in 5 mM NaH,PO,, 15 mM Na,HPO,, 0-5 M NaC1, pH 7.0, and passed four times over an immunoaffinity chromatography column containing rabbit anti-PA47 sera bound to hydrazide resin according to the manufacturer's instructions (Bio-Rad). The unbound PA17 pool was adjusted to 4 M urea and the volume reduced by using a 10 kDa cutoff membrane. Fragments were stored at -70 "C.
Trypsin-treated PA (T-PA), chymotrypsin-treated PA (Ch-PA), chymotrypsin-and trypsin-treated PA (Ch/T-PA ; Novak e t al., 1992), and chymotrypsin-treated PA63 (Ch-PA63) were also prepared but without subsequent chromatography.
Hybridomas. Female BALB/c mice were immunized subcutaneously (0.4 ml) and intraperitoneally (0.2 ml) with purified PA63 (50 pg) in Freund's complete adjuvant (1 : l ; day 0) or Freund's incomplete adjuvant (1 : 1 ; day 14). Subcutaneous injections were administered in two sites. On days 33 and 34, mice were injected both intravenously (0.1 ml) and intraperitoneally (0.1 ml) with 100-200 pg of PA63 in saline. Hybrid cell lines, prepared by fusing spleen cells with SP2/0-Ag14 myeloma cells (Earley & Osterling, 1985) , were screened by ELISA for PA63 reactivity. The preparation of ascites, quantification of Ig, and determination of antibody subclass were as described previously (Little e t al., 1988) .
Previously described mAbs produced against PA (Little et al., 1988) were also included in the analysis. Therefore, for identification purposes, the mAbs are designated with a subscript of the immunizing antigen: PA63 or PA.
Polyclonal antiserum. Fragments of PA, generated by limited proteolysis with chymotrypsin and trypsin (Novak et af., 1992), were separated on 20 cm SDS-PAGE gels (12 %, w/v, acrylamide). The resolved protein bands were identified by staining with Pro-Green (Integrated Separation Systems) according to the manufacturer's instructions, excised, destained, rinsed in distilled water, and frozen at -20 OC. Polyclonal rabbit antiserum against PA47 and PA17 was prepared by injecting the rabbits intramuscularly and subcutaneously with polyacrylamide gel slices that contained the respective fragment homogenized with adjuvant (1 : 1). The primary injection included Freund's complete adjuvant ; all subsequent injections included Freund's incomplete adjuvant. Polyclonal antiserum against PA was produced in rabbits injected intramuscularly and subcutaneously with purified PA (100 pg protein) and Freund's complete or incomplete adjuvant as above.
ELISA and ELISA competition assay. The ELISA was as described previously (Little et al., 1990 al., 1984) , and ascitic fluid after preincubation for 1 h at 37 OC. Ascitic fluids that protected or delayed the death of rats were tested at lower concentrations until no protection was observed. All mAbs were tested for neutralizing ability in vivo.
Cellular neutralization assays. An in vitro colorimetric assay, developed to assess cell growth and viability (Green et al., 1984; Mosmann, 1983) , was used as described previously (Little et al., 1990) to study the interactions between mAbs, PA, LF and J774A.1 murine macrophage cells. Briefly, the three different in vitro neutralization protocols were as follows. (i) (PA + LF + mAb) ; ascitic fluid containing mAb was preincubated in lethal toxin (400 ng PA ml-' plus 40 ng LF ml-') for 1 h at 37 OC before adding to J774A.1 cells. (ii) (PA+cell); J774A.1 cells were preincubated with PA (400 ng ml-') at 4 "C for 2 h. In separate 96-well plates, ascitic fluids containing mAb were preincubated in LF (40 ng ml-') at 37 OC for 1 h. After aspirating the PA from the cells, mAb dilutions in LF were added. (iii) (PA + LF + cell) ; J774A. 1 cells were washed twice in cold incubation medium and then were preincubated with PA (800 ng ml-l) and LF (80 ng ml-l) at 4 OC for 2 h. After washing the cells twice with cold incubation medium, dilutions of ascitic fluids containing mAb were added. Only those mAbs that neutralized lethal toxin in the first protocol were tested in the last two protocols. Cell viability was calculated by using the average A,,, of pairs of wells receiving either toxin plus mAb or mAb alone. We chose the concentration of ascites Ig (pg ml-l) that inhibited 80 YO of cell death as a quantitative measure of the in uitro neutralizing ability of the mAb. Absorbance readings were obtained using a Bio-Tek model EL-310 autoreader.
Binding studies with 1251-PA. PA was iodinated by using the 1251-Bolton-Hunter reagent (Amersham) (specific activity 2.0 x 10' c.p.m. pg-l to 5.0 x lo6 c.p.m. pg-l). mAbs (100 pg ascites Ig ml-') were preincubated with 1251-PA (0.075 pg ml-') for 2 h at 4 O C and added to L6 rat skeletal muscle myoblast cells in 24-well plates (2 x lo5 to 4 x lo5 ml-l) previously washed with cold Hanks' balanced salt solution (HBSS). After incubating for 6 h at 4 O C on ice, the monolayers were washed three times with cold HBSS, solubilized by adding 0.75 ml 0.1 M NaOH, and the radioactivity measured. Specific binding was determined by subtracting nonspecific background binding from total binding. Nonspecific binding, determined by adding 250-fold excess of unlabelled PA in addition to 12'I-PA, was less than 10% of total binding. Data are reported as percentage inhibition of the specific binding occurring in control wells incubated without mAb. Assays were done in triplicate.
Binding studies with lZ51-LF. Binding studies, with LF iodinated by the chloramine-T method (specific activity 2.0 x lo7 c.p.m. pg-l to 3.0 x lo7 c.p.m. pg-l), were based upon previously described methods (Little et a/., 1990). L6 cells (2 x lo5 to 4 x lo5 ml-l) were preincubated with 400 pl PA (0.075 pg ml-l) for 18 h at 4 O C on ice. Cells were washed with cold HBSS and then incubated with 400 p1 ascitic fluid containing mAb (100 pg Ig ml-l) for 1 h at 4 OC, followed by the addition of 20 pl per well of 1251-LF (final concentration 50 ng ml-l). After incubating for 2 h at 4 "C on ice, monolayers were washed three times with cold HBSS, solubilized with 075 ml 0.1 M NaOH, and the mean count recorded from triplicate samples. Specific binding was determined by subtracting nonspecific binding from total binding. Nonspecific binding, determined by adding 1251-LF to cells in the absence of PA, was less than 15 % of total binding. Data were reported as percentage inhibition of the specific binding occurring in control wells incubated without mAb.
lmmunoblot analysis of PA fragments. Fragments of PA, prepared by limited proteolysis with chymotrypsin (125 pg ml-l) or chymotrypsin (125 pg ml-l) and trypsin (12-5 pg ml-l) (Novak et al., 1992) , were separated by SDS-PAGE under reducing conditions on 10% (w/v) Tricine gels (Novex). Proteins were electrophoretically transferred to 0.2 pm pore nitrocellulose (Towbin eta!., 1979). The membranes were blocked with 5 % (w/v) nonfat milk in 20 mM Tris/HCl, 0.5 M NaC1, pH 7. from the C-terminal coding region of the PA gene, pag, in pBluescript (KS +), was described previously (Little & Lowe, 1991) . Cells, harvested from cultures grown as described by Little & Lowe (1991) , were suspended in 25 mM Tris/HCl (pH 8.5), 100 mM NaC1, 30% (w/v) sucrose, 1 mM PMSF, 1 mM EDTA and 1 mM 1,lO-phenanthroline. Lysozyme (300 pg in 50 pl 0.1 M EDTA) was added and the cells were incubated on ice for 30 min. The suspension was then centrifuged at 1OOOOg for 10 min. The supernatant fluid was collected and analysed by SDS-PAGE on 10% Tricine gels (Novex). Separated proteins were electrophoretically transferred to 0.45 pm nitrocellulose (Towbin et al., 1979) , and membranes were developed as an immunoblot as described above for the PA fragments, using PBS buffers instead.
Construction of recombinant clones pYS2, pYD17 and pY S10, which express full-length pag, a 7-amino-acid deletion and a 14-amino-acid deletion from the C-terminus of PA, respectively, was described previously (Singh etal., 1989 (Singh etal., ,1991 . Protein from pYD17 was purified as described by Singh et al. (1991) . Cells from 100 ml cultures of pYS2 or pYS10, induced with IPTG, were suspended in 5 ml0.1 M HEPES, pH 7*4,10 mM EDTA, 5 % (v/v) heat-inactivated foetal bovine serum, 2 % (v/v) glycerol and 1 mM 1,lO-phenanthroline and sonicated in four 30 s intervals. Supernatants, collected after centrifugation for 15 min at lOOOOg, were purified on a mAb 10G4,, column. Protein was eluted with 2 M sodium thiocyanate in 20 mM HEPES, pH 7.4, after the column was washed with 40 ml PBS. Eluted protein was subjected to SDS-PAGE after buffer exchange to 10 mM HEPES, pH 7.4, electrophoretically transferred to nitrocellulose, and analysed in an immunoblot as above.
Recombinant plasmids pYD2 and pYD3, which express a 65-and a 134-amino-acid deletion, respectively, from the Cterminus of PA, were generated by PCR amplification of the native PA gene from pYS5 template . A nonmutagenic oligonucleotide primer, corresponding exactly to nucleotides 2842-2864 of pag (numbering system of Welkos et a/., 1988), a region containing a PstI recognition site unique to pag and pYS5, was used in all amplification reactions (Singh et al., 1991) . Mutagenic oligonucleotide primers were designed to be complementary to the intended new 3' end of the PA gene and to introduce two in-frame stop codons and a unique BamHI site. For pYD2 the primer for deleting nucleotides 3901-4095 was 5' CATTATATTTTTTAAAATCTATAAATGGATCC-TATTATTGCCGTAAACTAGAAATATTC 3' and for pYD3 the primer for deleting nucleotides 3694-4095 was 5' TATCATAATGAAAACG 3'. Mutant constructs were confirmed by sequence analysis. Plasmids pYD2, pYD3 and pYS5 were transformed into Bacillus subtilis WB6OO (Wu et al., 1991) , which lacks six major extracellular proteases. Cultures were grown in brain heart infusion medium containing 5 pg kanamycin sulfate ml-' at 37 "C for 6-8 h until the ODeo0 read 2-2-2.5 using a Shimadzu UV16OU spectrophotometer. The cultures were centrifuged at 10000 g and the supernatants were removed and supplemented to 1 mM PMSF and 10 mM EDTA. Supernatants were concentrated threefold with a Centriprep 30 device (Amicon) and analysed by immunoblot analysis after SDS-PAGE, as described above.
CTACTGACTCATCCGCCCCAGGATCCTATTAATTTC-

RESULTS
In wivo neutralization of lethal toxin
Two mAbs against PA neutralized lethal toxin activity 100 % of animals (three of three) with 100 pg and 1000 pg ascites Ig, respectively. Table 2) . mAbs 3B6,,, 14B7,, and 10E10p~63 did not neutralize lethal toxin activity under these conditions (Table 2 ). When J774A. 1 cells were preincubated with PA (800 ng ml-') and LF (80 ng ml-l) before addition of mAbs [experiment (iii), PA + LF + cells], five mAbs demonstrated only very weak neutralizing ability (1 G3PA63, 2D3,,, 2D5,,, 1 OD2,, and 10G4,,) ( Table 2 ).
As shown in Table 2 , two major groups of neutralizing activities were identified. The first group (1 G3p~63, 2D3,,, 2DspA, 10D2,, and 10G4,,) neutralized lethal toxin cytolytic activity whether they were added before or after PA bound to cells. However, only mAb 1G3p~63 was highly potent before and after PA bound to cells. The second group (3B6,,, 14B7,, and 1 OEl o,,,,) neutralized lethal toxin cytolytic activity only when combined with PA before being added to cells, and was inactive when added after PA had bound.
Seven of the mAbs were IgG, and one was IgG,, subtype ( Table 2) .
Inhibition of toxin formation on target cells
Binding studies demonstrated that of the eight mAbs that neutralized lethal toxin cytolytic activity in the macro-10D2,,, inhibited binding of 1251-LF to cell-bound PA by 78-102 YO (Table 3) . mAbs 3B6,,, 14B7,, and 10E10PA63 inhibited binding of 1251-PA to the receptor by 90-98% (Table 3) . mAb 10G4,,, which neutralized lethal toxin cytolytic activity only at high concentrations (Table 2) , had only a modest effect on inhibition of binding of 1251-PA to the receptor and had no effect on binding of '251-LF to cell-bound PA (Table 3) .
phage CytOlySiS assay, four, ~G~P A~~, ~D~P A , 2 D 5 p~ and * Antibody subtypes were reported previously (Little et al., 1988) . (Little et al., 1988) .
Competition between mAbs for antigenic sites
A competitive-binding E L S A against PA6, antigen identified three separate antigenic groups among the neutralizing mAbs (Table 4) . Two separate antigenic regions were recognized by mAbs that inhibited binding of 1251-LF to cell-bound PA, while mAbs that inhibited binding of 1251-PA to cells recognized a single antigenic region. mAB 1 OG4,, recognized the same antigenic region as identified by mAbs 2D3,,, 2D5,, and 10D2pA.
Location of antigenic region recognized by mAb
ELISA titration curves of mAb 1G3p~63 ascites against protease-treated preparations and selected fragments of PA demonstrated that this mAb reacted most strongly
G3PA63
with PA63 and Ch-PA63, with lesser reactivity against PA and T-PA (Fig. 2) . No other PA fragments were recognized by mAb 1G3p~6, ascites by ELISA. Immunoblots with mAb 1 G3p~63 demonstrated reactivity against proteolytic fragments PA37 and PA17 but not PA47 (Fig.  3, lanes 1 and 2) . Major fragments in these preparations were identified by rabbit polyclonal antiserum against PA (Fig. 3, lanes 3 and 4) . The higher than expected apparent mass of the PA17 fragment was noted previously (Novak et al. , 1992) .
Location of the antigenic region recognized by mAbs 2D3pA, 2D5, , 10D2, and 1OG4pA
ELISA titration curves of mAb 2D3,, against selected fragments of PA showed that this mAb recognized an antigenic region on the PA47 fragment (Fig. 4) . Similar results were observed for mAbs 2D5,,, 10D2pA and 10G4,, (data not shown). Immunoblot analysis with mAb 2D3,, of fragments resulting from chymotrypsintreated or chymotrypsin-and trypsin-treated PA preparations separated by SDS-PAGE also demonstrated recognition of an epitope within the PA47 fragment (Fig.  5, lanes 1 and 2) . Similar results were observed for mAbs 2D5,,, 10D2pA and 10G4,, (data not shown). Immunoblots developed with rabbit anti-PA17 antibody showed reactivity with the PA37 and PA1 7 fragments, which confirmed their presence in these preparations (Fig. 5,  lanes 3 and 4) .
Immunoblots of recombinant proteins expressing deletions of pag generated into the C-terminal coding region of PA showed that mAb 2D3,, recognized full-length PA produced by the parent clone pYS5 and deletions of 65 and 134 amino acids, PA-670 and PA-601, respectively (Fig. 6, lanes 1-3) . However, mAb 2D3,, did not recognize a deletion of 155 amino acids (PA-580; Fig. 6 , lane 4). Similar results were observed with mAbs 2D5,,, 10D2pA and 10G4,,(data not shown). Immunoblots with -PA20
21.5-rabbit polyclonal antiserum against PA identified PA produced by the deletion clones (Fig. 6, lanes 5-8) . These results suggest that mAbs 2D3,,, 2D5,,, 10D2,, and 1 OG4,,recognized an epitope between amino acids Ile-581 and Asn-601. 
Hg.
3 . lmmunoblot analysis of fragments generated by limited proteolysis of PA with chymotrypsin or chymotrypsin and trypsin using mAb 1G3p~63 (lanes 1 and 2) or rabbit polyclonal antiserum against PA (lanes 3 and 4). Samples were loaded as follows: Ch-PA, lanes 1 and 3; Chn-PA, lanes 2 and 4. Molecular mass markers are indicated on the left and the major fragments of PA are indicated on the right.
Location of antigenic region recognized by mAb 3B6, , 14B7, and 10E10, MAbs 3B6,,, 14B7,, and 10E10p~63 also recognized an antigenic region on the PA47 fragment, as demonstrated by similar titration curves and immunoblot results against proteolytic fragments of PA as 2D3,, (data not shown).
mAb 10E10p~63 did not recognize the recombinant protein expressed by deletion clone pBKPPAA65, PA-580 (data not shown), findings similar to mAbs 3B6,, and 14B7,, (Little & Lowe, 1991) and 2D3,, (Fig. 6 ).
Immunoblots showed that mAb 3B6,, recognized PA-735 (pYS2) and deletion clones PA-728 and PA-721 ( 7, lanes 1-3). mAb 3B6,, did not recognize deletion clone PA-670 (Fig. 7, lane 4) . Similar results were observed with mAbs 14B7,, and lOElOpA,, (data not shown). These results suggest that these mAbs map between Asp-671 and Ile-721. Immunoblots with rabbit polyclonal antiserum against PA identified PA produced by the deletion clones (Fig. 7, lanes 5-8) . The proposed model for the formation of lethal or oedema toxin from B. antbracis identifies regions of PA that interact with cell receptors, bind LF or EF, and translocate the toxin into the cytosol . The extreme C-terminus of PA takes part in binding to cell receptors (Singh et al., 1991) . We previously reported that mAbs 3B6,, and 14B7,, blocked binding of PA to cells (Little e t al., 1988) and identified an antigenic region within the 155 C-terminal amino acids of PA (Little & Lowe, 1991) . The activities of mAbs 3B6,,, 14B7,, and 10E10p~63 in the in nitro macrophage cytolysis assay provides additional indirect evidence that PA binding is required for toxin formation. This report further maps the antigenic region recognized by mAbs that block the binding of PA to cells between amino acids Asp-671 and Ile-721. In contrast to an earlier report (Singh etal., 1991) , the immunoblot reactivity we observed between these mAbs and the PA deletion proteins may have been due to a partial restoration of native conformations of the proteins or epitopes during electrophoretic transfer to nitrocellulose in the presence of Towbin buffer (Towbin et al., 1979) , which lacks SDS.
Identification of antigenic region recognized by mAbs 2D3, , 2D5, and 1oDzpA
Two different, non-competitive antigenic regions were defined with respect to location on PA63 by the competitive-binding ELISA and immunoblot analysis by mAbs that neutralized lethal toxin activity by inhibiting the binding of LF to cell-bound PA. One region, recognized by mAbs 2D3,,, 2D5,, and 10D2,,, resides within the PA47 fragment. Immunoblots of recombinant proteins expressing deletions ofpag generated into the Cterminal coding region of PA demonstrated that these mAbs recognized an epitope between amino acids Ile-581 and Asn-601. mAb 10G4,,, which also mapped to the same region, was able to neutralize lethal toxin activity in vitro, probably due to steric hindrance effects, as it did not inhibit significantly the binding of 1251-PA to cells or 1251-LF to cell-bound PA. The absence of any interference between these mAbs and mAbs that block binding to cells, such as 3BbPA, 14B7,, and 10E10pA63, in the competition ELISA, their inability to significantly block 1251-PA binding to the cell receptor, and their ability to neutralize lethal toxin activity in the macrophage cytolysis assay after PA was bound to cells suggest that the Cterminal portion of PA plays a role in interaction with cell receptors as well as with LF. Although a successive loss of C-terminal amino acids demonstrated a corresponding decreased ability to bind to cell receptors, recombinant proteins with deletions of up to seven amino acids were able to bind LF or EF, similar to full-length PA (Singh e t al., 1991) . We have not yet evaluated the ability of recombinant proteins with deletions longer than 14 amino acids to interact with either LF or EF.
Identification of antigenic region recognized by mAb
The second antigenic region recognized by mAbs that inhibited binding of 1251-LF to PA was defined by mAb 1 G3PA63. This mAb appeared to be more directly involved in LF binding than the other non-competitive region was at least 10-fold more active in neutralizing toxin activity when added after PA bound to cells and completely blocked binding of 1251-LF to PA. The epitope recognized by mAb 1G3p~63 was identified on PA17 by
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represented by 2D3,,, 2DsPA and 10D2,,. mAb 1 G3p~63 immunoblot analysis. Reactivity of mAb 1 G3p~63 with PA37 and PA17, however, was not confirmed by ELISA. The different results observed between the two assays may be explained by differences in the preparation of the fragments rather than in differences in immobilization interactions of the antigen on plastic or nitrocellulose (Brennand et al., 1986) . The PA37 and PA17 fragments used in the ELISA were prepared in the presence of 5 M urea; upon removal of urea by buffer exchange or dilution, complete or proper refolding of the molecule or epitope may not have occurred. We also did not observe reactivity of mAb 1G3PA63 to PA17 prepared in the presence of 5 M urea and passively bound to nitrocellulose or polyvinylidene fluoride membranes which were analysed by immunoblotting (data not shown). The antigenic region recognized by 1 G3p~63 on PA37 and PA1 7 may have been restored on immunoblots after SDS-PAGE during electrophoretic transfer in Towbin buffer, which lacks SDS.
ELISA reactivity of mAb 1G3p~63 against PA63 was 2.5 orders of magnitude greater than against PA or T-PA, suggesting that proteolysis and subsequent removal of the N-terminal 20 kDa fragment is required to expose the epitope recognized by this mAb. mAb 1G3p~63 retained its reactivity against Ch-PA63, suggesting that the chymotrypsin site is not part of its epitope. Any conformational changes resulting from the binding of antigen to plastic (Hollander & Katchalski-Katzir, 1986 ) apparently did not expose the antigenic site(s) after proteolytic nicking of PA.
Whether these mAbs directly inhibit binding of PA to cells or of LF to cell-bound PA, or whether they do so indirectly, by steric hindrance or by causing a change in conformation of PA upon binding, is not known. If the inhibition is effected indirectly, the antigenic regions identified by these mAbs in this study may not accurately reflect the actual contact regions with the cell receptor or effector molecule, LF or EF. Identifying mAbs that neutralize lethal toxin activity will enable us to clarify the role of the toxins in pathogenesis as well as the role of antibodies in immunity, and to test their efficacy in protection against anthrax infection. Furthermore, specific knowledge of the binding site on PA for LF and EF suggests that PA fragments or peptides containing this site may be effective as vaccines against infection. Studies are presently under way to characterize further the antigenic regions recognized by these mAbs.
Putative translocation region on PA not identified by mAbs
In addition to binding to cells and binding LF or EF, PA is also postulated to contain a region required for translocation of the toxin . The putative region for this activity has been associated with the chymotrypsin site, Phe-313 to Asp-315 (Novak e t al., 1992 , Singh e t al., 1994 . Lethal toxin constructed with PA previously treated with chymotrypsin (Novak e t al., 1992) or mutated by altering the residues in this region (Singh e t al., 1994) , was nontoxic to cells. 
